Changes in liver function and body composition by direct‐acting antiviral therapy for hepatitis C virus infectionRyosuke Sugimoto, Yoshiyuki Takei, Norihiko Yamamoto et al.|Hepatology Research|2017Cited by 31
Factors contributing to the development of overt encephalopathy in liver cirrhosis patientsMotoh Iwasa, Yoshiyuki Takei, Ryosuke Sugimoto et al.|Metabolic Brain Disease|2016Cited by 28
Neutrophil gelatinase‐associated lipocalin level is a prognostic factor for survival in rat and human chronic liver diseasesKyoko Yoshikawa, Yoshiyuki Takei, Motoh Iwasa et al.|Hepatology Communications|2017Cited by 27
Ratio between estimated glomerular filtration rates of creatinine and cystatin C predicts overall survival in patients with hepatocellular carcinomaYasuyuki Tamai, Yoshiyuki Takei, Motoh Iwasa et al.|Hepatology Research|2018Cited by 20